CERTARA INC. - COMMON

Certara Reports Third Quarter 2022 Financial Results

07 Nov 2022 15:15:01 By Nasdaq GlobeNewswire

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase

07 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

02 Nov 2022 16:00:00 By Nasdaq GlobeNewswire

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions

19 Oct 2022 07:00:02 By Nasdaq GlobeNewswire

Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022

13 Oct 2022 06:45:00 By Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

31 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

Certara Announces Secondary Offering

11 Aug 2022 15:38:42 By Nasdaq GlobeNewswire

Certara Reports Second Quarter 2022 Financial Results

09 Aug 2022 15:15:01 By Nasdaq GlobeNewswire

Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module

05 Aug 2022 07:00:00 By Nasdaq GlobeNewswire

Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies

28 Jul 2022 07:00:01 By Nasdaq GlobeNewswire

Certara Appoints Rosemary Crane as New Independent Board Member

25 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Certara Appoints Eran Broshy as New Independent Board Member

13 Jul 2022 07:00:01 By Nasdaq GlobeNewswire

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

12 Jul 2022 07:00:01 By Nasdaq GlobeNewswire

Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development

28 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics

21 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

Certara Reports First Quarter 2022 Financial Results

05 May 2022 15:15:00 By Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

03 May 2022 15:30:00 By Nasdaq GlobeNewswire

Certara to Report First Quarter 2022 Financial Results on May 5th, 2022

20 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Certara Reports Fourth Quarter and Full Year 2021 Financial Results

01 Mar 2022 15:15:00 By Nasdaq GlobeNewswire

U.S. FDA Licenses Certara’s Immunogenicity Simulator

23 Feb 2022 15:30:00 By Nasdaq GlobeNewswire